Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The University of Texas Medical Branch, Galveston
With
United States Department of Defense
American Burn Association
A safety and efficacy trial is needed in order to determine the safety of propranolol treatment in adult burn patients, identify which subpopulations may be most likely to benefit from propranolol treatment and to identify propranolol dose levels that are not only safe but potentially effective.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
≥ 20% Total Body Surface Area (TBSA) burn with anticipated operation need on admission
Age ≥ 18 years
Admission within 72 hours of injury
You may not be if
Age \<18
Patients unlikely to survive injury or with ;age = total burn size ≥ 130
Electrical or deep chemical burn
Malignancy currently undergoing treatment or history of cancer treatment within 5 years
History of HIV or AIDS
Presence of anoxic brain injury that is not expected to result in complete recovery
Currently treated for Chronic Obstructive Pulmonary Disease (COPD), asthma or other chronic pulmonary conditions
History of Congestive Heart Failure (CHF) (ejection fraction \< 20%)
Pre-injury medications including blocking agents (alpha or beta) or other anti-arrhythmic drugs
Pregnant women
Prisoners
History of cardiac arrhythmia requiring medication
Medical condition requiring glucocorticoid treatment
Patients with concurrent conditions that in the opinion of the investigator may compromise patient safety or study objectives
Clareo Health | Protective Effects of Propranolol in Adults
